Role of antiplatelet therapy in cardiovascular disease II: Ischemic stroke
Authors: Jeffrey J. Cavendish1; Steven C. Cramer2; Glenn D. Graham3
Source: Current Medical Research and Opinion, Volume 20, Number 11, November 2004 , pp. 1845-1849(5)
Publisher: Informa Healthcare
- Free Content
- New Content
- Subscribed Content
- Free Trial Content
Abstract:
The etiology of cerebrovascular disease is heterogeneous, with the majority of strokes being of ischemic origin. Transient ischemic attack is now considered to be an important precursor and long-term risk factor for ischemic stroke. Given the lack of acute therapies for ischemic stroke, current treatments focus on secondary prevention through risk-factor management, pharmacotherapy and interventional approaches. As illustrated in this paper, antiplatelet agents (e.g. clopidogrel, aspirin, dipyridamole) are the cornerstone of therapy for prevention of recurrent ischemic stroke.Keywords: ANTIPLATELET; ATHEROTHROMBOSIS; ISCHEMIC STROKE; TRANSIENT ISCHEMIC ATTACK
Document Type: Research article
DOI: 10.1185/030079904X10674
Affiliations: 1: Department of Cardiology, Naval Medical Center, San Diego, CA, USA 2: Departments Neurology and Anatomy and Neurobiology, UCI Medical Center, University of California Irvine, Orange, CA, USA 3: Departments of Neurology, Radiology, and Neurosciences, Albuquerque VA and Neurology/127, VA Medical Center, University of New Mexico School of Medicine, Albuquerque, NM, USA
- Free Content
- New Content
- Subscribed Content
- Free Trial Content
Click here for Page Help